Dashboard
Manage Tickers

FGEN FIBROGEN INC

Nasdaq fibrogen.com


$ 9.20 $ 0.00 (0 %)    

Thursday, 13-Nov-2025 07:35:23 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 618.72 $ 0.00 (0 %)
DIA $ 481.48 $ 0.00 (0 %)
SPY $ 681.16 $ 0.00 (0 %)
TLT $ 89.80 $ 0.00 (0 %)
GLD $ 388.49 $ 0.00 (0 %)
$ 9.13
$ 10.09
$ 9.17 x 10
$ 10.08 x 28
-- - --
$ 4.50 - $ 21.94
86,762
na
36.93M
$ 1.05
$ 0.17
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-12-2025 03-31-2025 10-Q
4 03-17-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-06-2024 03-31-2024 10-Q
8 02-26-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-07-2023 06-30-2023 10-Q
11 05-08-2023 03-31-2023 10-Q
12 02-27-2023 12-31-2022 10-K
13 11-07-2022 09-30-2022 10-Q
14 08-08-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-01-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 03-02-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-27-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-01-2017 12-31-2016 10-K
37 11-08-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

correction-fibrogen-q3-eps-325-beats-400-estimate-sales-1076m-miss-1640m-estimate
CORRECTION: FibroGen Q3 EPS $(3.25) Beats ...
11/11/2025 00:25:19

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(3.25) per share which beat the analyst consensus estimate of $(4.00) by 1...

hc-wainwright--co-reiterates-buy-on-fibrogen-maintains-43-price-target
HC Wainwright & Co. Reiterates Buy on Fibr...
09/24/2025 14:25:18

HC Wainwright & Co. analyst Matthew Keller reiterates FibroGen (NASDAQ:FGEN) with a Buy and maintains $43 price target.

fibrogen-begins-phase-2-trial-of-new-prostate-cancer-drug-fg-3246-with-ucsf-as-first-site
FibroGen Begins Phase 2 Trial Of New Prost...
09/24/2025 11:03:39

FibroGen, Inc. (NASDAQ:FGEN) today announced the initiation of the Phase 2 monotherapy, dose-optimization trial of FG-3246, a p...

fibrogen-confirms-regulatory-approval-for-sale-of-fibrogen-international-hong-kong-ltd-to-astrazeneca-treasury-limited
FibroGen Confirms Regulatory Approval For ...
08/18/2025 11:11:53

Sale of FibroGen China remains on track to close in 3Q 2025

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 12:08:34

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/11/2025 21:06:28

Core News & Articles
FibroGen To Sell China Business To AstraZe...
08/11/2025 20:37:58

Recent Developments and Key Highlights of Second Quarter 2025: Sale of FibroGen China to AstraZeneca now expected to be for a t...

fibrogen-q2-eps-188-beats-225-estimate-sales-135m-miss-263m-estimate
FibroGen Q2 EPS $(1.88) Beats $(2.25) Esti...
08/11/2025 20:22:10

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(1.88) per share which beat the analyst consensus estimate of $(2.25) by 1...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

uncovering-potential-fibrogens-earnings-preview
Uncovering Potential: FibroGen's Earnings ...
08/08/2025 20:05:09

hc-wainwright--co-maintains-buy-on-fibrogen-raises-price-target-to-43
HC Wainwright & Co. Maintains Buy on Fibro...
08/07/2025 17:03:29

HC Wainwright & Co. analyst Matthew Keller maintains FibroGen (NASDAQ:FGEN) with a Buy and raises the price target from ...

fibrogen-announces-positive-feedback-from-type-c-meeting-with-fda-supporting-advancement-of-roxadustat-for-treatment-of-anemia-in-patients-with-lr-mds-and-high-rbc-transfusion-burden
FibroGen Announces Positive Feedback From ...
08/07/2025 11:10:00

FibroGen has reached agreement with the FDA on important design elements for a pivotal Phase 3 clinical trial for roxadustat fo...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/02/2025 21:05:48

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
06/17/2025 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
06/16/2025 23:50:04

fibrogen-terminates-license-agreement-with-hifibio-transfers-anti-ccr8-and-anti-gal-9-assets-and-secures-potential-royalties-from-future-sublicensing-or-commercialization
FibroGen Terminates License Agreement With...
06/13/2025 20:22:59

On June 12, 2025, FibroGen ("FibroGen" or the "Company") entered into a Termination, Asset Transfer and License...

adobe-fibrogen-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Adobe, FibroGen And Other Big Stocks Movin...
06/13/2025 12:22:26

why-rh-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket
Why RH Shares Are Trading Higher By Around...
06/13/2025 09:08:07

adobe-rh-and-3-stocks-to-watch-heading-into-friday
Adobe, RH And 3 Stocks To Watch Heading In...
06/13/2025 03:39:25

fibrogen-to-implement-1-for-25-reverse-stock-split-will-begin-trading-on-a-split-adjusted-basis-on-june-17-2025
FibroGen To Implement 1-For-25 Reverse Sto...
06/12/2025 20:02:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION